Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |